DISCLAIMER:
Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.
MO-H345-IePD-F5-4 | Real-Time Tracking Diaphragm Motion On During-Treatment KV Cone Beam Projection Images Using ResNet50 J Liang*, Q Liu, E Porter, D Yan, Beaumont Health System, Royal Oak, MI |
MO-H345-IePD-F5-5 | A Deep Learning Fiducial Marker Detection Algorithm for Beam's-Eye-View Marker Tracking for Liver Cancer Patients D Chrystall1*, E Hewson2, C Sengupta2, A Mylonas2, T Wang3, R O'Brien2, Y Lee4, P Poulsen5, D Nguyen2, P Keall2, J Booth1, (1) Northern Sydney Cancer Centre, St Leonards, NSW, AU, (2) The University of Sydney, Sydney, NSW, AU, (3) Western Sydney Local Health District, NSW, AU, (4) Princess Alexandra Hospital, Qld, AU,(5) Aarhus University Hospital, Aarhus N, DK, |
MO-PinS-INV1-0 | Respiratory Motion Management Systems C Peeler1*, K Kvasnica2*, S Mutic3*, P Barry4*, B Waghorn5*, B Lu6*, (1) UT MD Anderson Cancer Center, Houston, TX, (2) Accuray, (3) Varian Medical Systems, Creve Coeur, MO, (4) Elekta, Inc., Atlanta, GA, (5) Vision RT Ltd, Alpharetta, GA, (6) University of Florida, Gainesville, FL |
MO-PinS-INV1-1 | Respiratory Motion Management Systems C Peeler1*, K Kvasnica2*, S Mutic3*, P Barry4*, B Waghorn5*, B Lu6*, (1) UT MD Anderson Cancer Center, Houston, TX, (2) Accuray, (3) Varian Medical Systems, Creve Coeur, MO, (4) Elekta, Inc., Atlanta, GA, (5) Vision RT Ltd, Alpharetta, GA, (6) University of Florida, Gainesville, FL |
MO-PinS-INV1-2 | Transition Introduce Exhibitor C Peeler1*, K Kvasnica2*, S Mutic3*, P Barry4*, B Waghorn5*, B Lu6*, (1) UT MD Anderson Cancer Center, Houston, TX, (2) Accuray, (3) Varian Medical Systems, Creve Coeur, MO, (4) Elekta, Inc., Atlanta, GA, (5) Vision RT Ltd, Alpharetta, GA, (6) University of Florida, Gainesville, FL |
MO-PinS-INV1-3 | Adapting to Respiratory Motion in Radiation Therapy C Peeler1*, K Kvasnica2*, S Mutic3*, P Barry4*, B Waghorn5*, B Lu6*, (1) UT MD Anderson Cancer Center, Houston, TX, (2) Accuray, (3) Varian Medical Systems, Creve Coeur, MO, (4) Elekta, Inc., Atlanta, GA, (5) Vision RT Ltd, Alpharetta, GA, (6) University of Florida, Gainesville, FL |
MO-PinS-INV1-4 | Transition Introduce Exhibitor C Peeler1*, K Kvasnica2*, S Mutic3*, P Barry4*, B Waghorn5*, B Lu6*, (1) UT MD Anderson Cancer Center, Houston, TX, (2) Accuray, (3) Varian Medical Systems, Creve Coeur, MO, (4) Elekta, Inc., Atlanta, GA, (5) Vision RT Ltd, Alpharetta, GA, (6) University of Florida, Gainesville, FL |
MO-PinS-INV1-5 | End to End (E2E) Solutions for Respiratory Motion Management in Radiotherapy C Peeler1*, K Kvasnica2*, S Mutic3*, P Barry4*, B Waghorn5*, B Lu6*, (1) UT MD Anderson Cancer Center, Houston, TX, (2) Accuray, (3) Varian Medical Systems, Creve Coeur, MO, (4) Elekta, Inc., Atlanta, GA, (5) Vision RT Ltd, Alpharetta, GA, (6) University of Florida, Gainesville, FL |
MO-PinS-INV1-6 | Transition Introduce Exhibitor C Peeler1*, K Kvasnica2*, S Mutic3*, P Barry4*, B Waghorn5*, B Lu6*, (1) UT MD Anderson Cancer Center, Houston, TX, (2) Accuray, (3) Varian Medical Systems, Creve Coeur, MO, (4) Elekta, Inc., Atlanta, GA, (5) Vision RT Ltd, Alpharetta, GA, (6) University of Florida, Gainesville, FL |
MO-PinS-INV1-7 | Active Breath-Hold with ABC™ for Motion Management with An Elekta Linear Accelerator for Stereotactic Body Radiotherapy of Lung Cancer C Peeler1*, K Kvasnica2*, S Mutic3*, P Barry4*, B Waghorn5*, B Lu6*, (1) UT MD Anderson Cancer Center, Houston, TX, (2) Accuray, (3) Varian Medical Systems, Creve Coeur, MO, (4) Elekta, Inc., Atlanta, GA, (5) Vision RT Ltd, Alpharetta, GA, (6) University of Florida, Gainesville, FL |
MO-PinS-INV1-8 | Transition Introduce Exhibitor C Peeler1*, K Kvasnica2*, S Mutic3*, P Barry4*, B Waghorn5*, B Lu6*, (1) UT MD Anderson Cancer Center, Houston, TX, (2) Accuray, (3) Varian Medical Systems, Creve Coeur, MO, (4) Elekta, Inc., Atlanta, GA, (5) Vision RT Ltd, Alpharetta, GA, (6) University of Florida, Gainesville, FL |
MO-PinS-INV1-9 | Vision RT: Surface Guided Radiation Therapy From Head to Toe C Peeler1*, K Kvasnica2*, S Mutic3*, P Barry4*, B Waghorn5*, B Lu6*, (1) UT MD Anderson Cancer Center, Houston, TX, (2) Accuray, (3) Varian Medical Systems, Creve Coeur, MO, (4) Elekta, Inc., Atlanta, GA, (5) Vision RT Ltd, Alpharetta, GA, (6) University of Florida, Gainesville, FL |
MO-PinS-INV1-10 | Transition Introduce Exhibitor C Peeler1*, K Kvasnica2*, S Mutic3*, P Barry4*, B Waghorn5*, B Lu6*, (1) UT MD Anderson Cancer Center, Houston, TX, (2) Accuray, (3) Varian Medical Systems, Creve Coeur, MO, (4) Elekta, Inc., Atlanta, GA, (5) Vision RT Ltd, Alpharetta, GA, (6) University of Florida, Gainesville, FL |
MO-PinS-INV1-11 | Clinic Experience of DIBH-Based Breast Treatment Using CRAD SystemClinic Experience of DIBH-Based Breast Treatment Using CRAD System C Peeler1*, K Kvasnica2*, S Mutic3*, P Barry4*, B Waghorn5*, B Lu6*, (1) UT MD Anderson Cancer Center, Houston, TX, (2) Accuray, (3) Varian Medical Systems, Creve Coeur, MO, (4) Elekta, Inc., Atlanta, GA, (5) Vision RT Ltd, Alpharetta, GA, (6) University of Florida, Gainesville, FL |
MO-PinS-INV1-13 | Q & A C Peeler1*, K Kvasnica2*, S Mutic3*, P Barry4*, B Waghorn5*, B Lu6*, (1) UT MD Anderson Cancer Center, Houston, TX, (2) Accuray, (3) Varian Medical Systems, Creve Coeur, MO, (4) Elekta, Inc., Atlanta, GA, (5) Vision RT Ltd, Alpharetta, GA, (6) University of Florida, Gainesville, FL |
PO-GePV-M-134 | Clinical Experience of ExacTrac to Guide Six Degree of Freedom Fiducial Marker Based Patient Positioning for Hypo-Prostate Fractionation R Sandhu*, C Knill, B Loughery, L Lin, Z Seymour, Beaumont Health - Dearborn, Dearborn, MI |
PO-GePV-M-148 | Retrospectively Evaluating CBCT Target Localization with MIP-Based Alignment and Comparing with AIP-Based Alignment L Wang1*, (1) Fox Chase Cancer Center, Philadelphia, PA |
PO-GePV-M-188 | How Fiducial Bracketing Affects Lung Tumor Tracking W Belcher*, J Jung, A Ju, K Yang, S Sharma, East Carolina Univ, Greenville, NC |
PO-GePV-M-197 | Evaluation of Internal Vs External Surrogate Motions During Pancreatic SBRT Treatments L Madden1*, A Briggs2, M Gargett1, R Brown1, E Hewson3, A Ahmed1, D Chrystall1, G Hruby1, A Kneebone1, J Booth1, (1) Northern Sydney Cancer Centre, St Leonards, NSW, AU, (2) Shoalhaven Cancer Care Centre, Nowra, NSW, AU, (3) University of Sydney, Sydney, NSW, AU, |
TU-A-202-2 | ASSET: Auto-Segmentation of the Seventeen SEgments for Ventricular Tachycardia Ablation in Radiation Therapy E Morris1*, R Chin1, T Wu1, C Smith1, S Nejad-Davarani2, M Cao1, (1) Department of Radiation Oncology, UCLA Health, Los Angeles, CA, (2) Department of Radiation Oncology, University of Michigan, Ann Arbor, MI |
TU-D1000-IePD-F5-5 | Daily Dose Assessment On Organ Variation and Target Coverage for Post-Operative Prostate Cancer Patients S Lo*, B Laughlin, T DeWees, M Beckett, K Tinnon, C Vargas, S Schild, N Yu, J Rwigema, S Keole, W Wong, Y Rong, Mayo Clinic Arizona, Phoenix, AZ |
TU-D1030-IePD-F6-4 | Quantifying Deformation Versus Artifact On 4DCT and Breathhold Scans A Bejarano Buele1*, Z Whiting2, J McKay1, T Denton1, J Tanyi2, J Treas2, A Bowers2, A Searfoss2, I Butterwick2, D Grimm3, J Grimm2, (1) Erlanger Health System, Chattanooga, TN (2) Geisinger Health, Danville, PA, (3) University of Pittsburgh. |
TU-F115-IePD-F7-4 | Single-Isocenter/Multi-Target (SIMT) SBRT Treatment On Ring-Gantry Halcyon: Risk of Target(s) Coverage Loss R Mallory*, M Bernard, M Kudrimoti, D Pokhrel, University of Kentucky, Lexington, KY |
TU-GH-BRB-5 | Automated Robotic Targeting System for In-Vivo Histotripsy Treatment M Wagner*, S Periyasamy, A Kutlu, J Swietlik, T Ziemlewicz, M Speidel, F Lee, P Laeseke, University of Wisconsin - Madison, Madison, WI |
WE-C1030-IePD-F2-1 | Deep-Learning Method for Segmenting Head and Neck Tumours in KV Images Acquired During Radiotherapy M Gardner1*, A Mylonas1, M Mueller1, Y Ben Bouchta1, J Sykes2, P Keall1, D Nguyen7, (1) University of Sydney, Sydney, NSW, AU (2) Blacktown Hospital, Blacktown, AU,(3) University of Technology Sydney, Ultimo, NSW |
WE-C930-IePD-F2-4 | Adaptive Predictions of Confidence Regions During Indirect Lung Tumor Tracking C Remy*1,2, H Bouchard1,2,3, (1) Université de Montréal, Département de Physique, Montréal, QC, CA, (2) Centre de recherche du Centre hospitalier de l'Université de Montréal, Montréal, QC, CA, (3) Département de radio-oncologie, Centre hospitalier de l'Université de Montréal, Montréal, QC, CA. |